News 23andMe Holding Co.

Equities

ME

US90138Q1085

Market Closed - Nasdaq Other stock markets 21:00:00 25/06/2024 BST			5-day change	1st Jan Change
0.442 ^USD	+0.48%		+8.09%	-51.61%

06-10	Sector Update: Health Care Stocks Advance Late Afternoon	MT
06-10	Sector Update: Health Care Stocks Retreat Monday Afternoon	MT

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Sector Update: Health Care Stocks Advance Late Afternoon	06-10	MT
Sector Update: Health Care Stocks Retreat Monday Afternoon	06-10	MT
23andMe Under Scrutiny by UK, Canadian Privacy Regulators Over October Data Breach	06-10	MT
23andMe Under Scrutiny by UK, Canadian Privacy Regulators Over October 2023 Data Breach	06-10	MT
Canada, UK launched joint probe into 23andMe data breach, says Canada	06-10	RE
23andMe Faces Joint Probe From UK Information Commissioner's Office, Canada's Privacy Commissioner Office Over 2023 Data Breach	06-10	MT
23andMe Launches New Genetic Report on Bipolar Disorder	06-05	GL
23andMe Launches New Genetic Report on Bipolar Disorder	06-05	AQ
23andMe and the Colorectal Cancer Alliance Collaborate to Help Advance Colorectal Cancer Research in the Black Community	06-04	GL
23andMe Therapeutics Announces Positive Preliminary Phase 2 Safety and Efficacy Results for 23ME-00610, targeting CD200R1, at the 2024 ASCO Annual Meeting	06-03	GL
23andMe Therapeutics Announces Positive Preliminary Phase 2 Safety and Efficacy Results for 23ME-00610, targeting CD200R1, at the 2024 ASCO Annual Meeting	06-03	AQ
23andMe Therapeutics Announces Positive Preliminary Phase 2 Safety and Efficacy Results for 23ME-00610, Targeting CD200R1, at the 2024 ASCO Annual Meeting	06-03	CI
Largest study on the LRRK2 variant leads to discoveries about health, ancestry, and history	05-29	GL
Earnings Flash (ME) 23ANDME Reports Q4 Revenue $64M, vs. Street Est of $61.5M	05-23	MT
23andMe Q4 Loss Widens, Revenue Decreases	05-23	MT
Transcript : 23andMe Holding Co., Q4 2024 Earnings Call, May 23, 2024	05-23
23andMe Holding Co. Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	05-23	CI
23andMe Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results	05-23	GL
23andMe Holding Co. Reports Unaudited Consolidated Goodwill Impairment for the Fourth Quarter Ended March 31, 2024	05-23	CI
Alibaba Cuts ADS Holdings by 60% in Q1	05-15	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

INTERVIEW - Anne Wojcicki, CEO of 23andMe: partnership with Amazon and cancer treatment results

July 13, 2023 at 07:26 pm